Cytomegalovirus Diagnostics Market by Test (Serology, Cell culture, Antigenemia assay, Polymerase Chain Reaction Amplification, Immunohistochemistry, Nucleic acid sequence-based amplification (NASBA), Hybrid capture assay), by Application (Retinitis, Pneumonia, Gastrointestinal Ulcers, Encephalitis, Others), By End-user (Hospitals, Diagnostic Centers, Others) and Geography

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Cytomegalovirus Diagnostics Market size was valued USD 73.6 million in 2021, growing at a CAGR of 6.1% during the forecast period 2022-28. Cytomegalovirus (CMV) infection is the common herpes virus infection having different symptoms which occurs in all ages of people around the world. Cytomegalovirus (CMV) infection is a communicable and easily prone through the body fluids like urine, saliva, blood, breast milk and semen. The infection may spread fast from urine or saliva from people who are infected with CMV having virus in their bodily fluids. The disease can transmit from pregnant to baby during delivery. Organ transplant and blood transfusion are the other way for the transmission for the disease. Cytomegalovirus diagnostics market is mainly propelling by the rise in the prevalence of CMV infections, growing awareness about herpes disease, initiatives taken by key market players for the diagnosis of CMV infection are propelling the growth of CMV diagnostics market. Moreover, rise in the support of government, and development of healthcare infrastructure are anticipated to propel growth of CMV diagnostics market. Lack of awareness and price sensitivity are the few factors hampering the growth of CMV diagnostics market.   Key Developments: In Jun 2017, Abbott received U.S. FDA approval for Real-time CMV molecular test, the only cytomegalovirus test which is available commercially which amplifies two selective regions of CMV genome In May 2016, Roche received U.S. FDA approval for its cytomegalovirus (CMV) test used in recipients of hematopoietic stem cells transplantation

Global Cytomegalovirus Diagnostics Market Summary

Study Period

2023-29

Base Year

2022

CAGR

x%

Largest Market

Asia-Pacific

Fastest Growing Market

North America
Cytomegalovirus Diagnostics Market Dynamics

Rise in diagnosis of CMV cases propelling the growth of global cytomegalovirus diagnosis market. According to Public Health Agency of Canada, 40%-100% of global population are having CMV antibody in the body. Patients with HIV and who has undergone organ transplantation, new-borns, and premature infants are having high risk of CMV infection. As per Centres for Disease Control and Prevention 1 per 150 infants are born with CMV infection in U.S. but only 1 in 5 infants are infected with CMV are having long term health issues.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Cytomegalovirus Diagnostics Market Segmentation

By Type
  • Serology
  • Cell culture
  • Antigenemia assay
  • Polymerase Chain Reaction Amplification
  • Immunohistochemistry
  • Nucleic acid sequence-based amplification (NASBA)
  • Hybrid capture assay
By Application
  • Retinitis
  • Pneumonia
  • Gastrointestinal Ulcers
  • Encephalitis
  • Others (Mouth Ulcers, Pharyngitis, etc.)
By End User
  • Hospitals
  • Diagnostic Centers
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1. Executive Summary 2. Global Cytomegalovirus Diagnostics Market Introduction 2.1. Global Cytomegalovirus Diagnostics Market – Taxonomy 2.2. Global Cytomegalovirus Diagnostics Market –Definitions 2.2.1. Test Type 2.2.2. End User 3. Global Cytomegalovirus Diagnostics Market Dynamics 3.1. Drivers 3.2. Restraints 3.3. Opportunities/Unmet Needs of the Market 3.4. Trends 3.5. Global Cytomegalovirus Diagnostics Market Dynamic Factors - Impact Analysis 4. Global Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 4.3. Market Opportunity Analysis 5. Global Cytomegalovirus Diagnostics Market, By Test Type, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.1. Serology 5.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.1.3. Market Opportunity Analysis 5.2. Cell Culture 5.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.2.3. Market Opportunity Analysis 5.3. Antigenemia Assay 5.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.3.3. Market Opportunity Analysis 5.4. Polymerase Chain Reaction Amplification 5.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.4.3. Market Opportunity Analysis 5.5. Immunohistochemistry 5.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.5.3. Market Opportunity Analysis 5.6. Nucleic Acid Sequence-based Amplification (NASBA) 5.6.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.6.3. Market Opportunity Analysis 5.7. Hybrid Capture Assay 5.7.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.7.3. Market Opportunity Analysis 6. Global Cytomegalovirus Diagnostics Market, By Application, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.1. Retinitis 6.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.1.3. Market Opportunity Analysis 6.2. Pneumonia 6.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.2.3. Market Opportunity Analysis 6.3. Gastroenteritis 6.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.3.3. Market Opportunity Analysis 6.4. Encephalitis 6.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.4.3. Market Opportunity Analysis 6.5. Others (Mouth Ulcers, Pharyngitis, etc.) 6.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.5.3. Market Opportunity Analysis 7. Global Cytomegalovirus Diagnostics Market, By End User, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.1. Hospitals 7.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.1.3. Market Opportunity Analysis 7.2. Diagnostic Centers 7.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.2.3. Market Opportunity Analysis 7.3. Others 7.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.3.3. Market Opportunity Analysis 8. Global Cytomegalovirus Diagnostics Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.1. North America 8.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.1.3. Market Opportunity Analysis 8.2. Europe 8.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.2.3. Market Opportunity Analysis 8.3. Asia-Pacific 8.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.3.3. Market Opportunity Analysis 8.4. Latin America 8.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.4.3. Market Opportunity Analysis 8.5. Middle East and Africa 8.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.5.3. Market Opportunity Analysis 8.6. Global Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Region, 2018 – 2024 9. North America Cytomegalovirus Diagnostics Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.1. Test Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 9.1.1. Serology 9.1.2. Cell culture 9.1.3. Antigenemia assay 9.1.4. Polymerase Chain Reaction Amplification 9.1.5. Immunohistochemistry 9.1.6. Nucleic acid sequence-based amplification (NASBA) 9.1.7. Hybrid capture assay 9.2. Application Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 9.2.1. Retinitis 9.2.2. Pneumonia 9.2.3. Gastrointestinal Ulcers 9.2.4. Encephalitis 9.2.5. Others (Mouth Ulcers, Pharyngitis, etc.) 9.3. End User Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 9.3.1. Hospitals 9.3.2. Diagnostic Centers 9.3.3. Others 9.4. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 9.4.1. U.S. 9.4.2. Canada 9.5. North America Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024 9.6. North America Cytomegalovirus Diagnostics Market Dynamics – Trends 10. Europe Cytomegalovirus Diagnostics Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 10.1. Test Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.1.1. Serology 10.1.2. Cell culture 10.1.3. Antigenemia assay 10.1.4. Polymerase Chain Reaction Amplification 10.1.5. Immunohistochemistry 10.1.6. Nucleic acid sequence-based amplification (NASBA) 10.1.7. Hybrid capture assay 10.2. Application Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.2.1. Retinitis 10.2.2. Pneumonia 10.2.3. Gastrointestinal Ulcers 10.2.4. Encephalitis 10.2.5. Others (Mouth Ulcers, Pharyngitis, etc.) 10.3. End User Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.3.1. Hospitals 10.3.2. Diagnostic Centers 10.3.3. Others 10.4. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 10.4.1. Germany 10.4.2. UK 10.4.3. France 10.4.4. Spain 10.4.5. Italy 10.4.6. Russia 10.4.7. Poland 10.4.8. Rest of Europe 10.5. Europe Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024 10.6. Europe Cytomegalovirus Diagnostics Market Dynamics – Trends 11. Asia-Pacific Cytomegalovirus Diagnostics Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 11.1. Test Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 11.1.1. Serology 11.1.2. Cell culture 11.1.3. Antigenemia assay 11.1.4. Polymerase Chain Reaction Amplification 11.1.5. Immunohistochemistry 11.1.6. Nucleic acid sequence-based amplification (NASBA) 11.1.7. Hybrid capture assay 11.2. Application Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 11.2.1. Retinitis 11.2.2. Pneumonia 11.2.3. Gastrointestinal Ulcers 11.2.4. Encephalitis 11.2.5. Others (Mouth Ulcers, Pharyngitis, etc.) 11.3. End User Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 11.3.1. Hospitals 11.3.2. Diagnostic Centers 11.3.3. Others 11.4. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 11.4.1. Japan 11.4.2. China 11.4.3. India 11.4.4. ASEAN 11.4.5. Australia & New Zealand 11.4.6. Rest of Asia-Pacific 11.5. Asia-Pacific Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024 11.6. Asia-Pacific Cytomegalovirus Diagnostics Market Dynamics – Trends 12. Latin America Cytomegalovirus Diagnostics Market Analysis, 2012 - 2012 - 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 12.1. Test Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.1.1. Serology 12.1.2. Cell culture 12.1.3. Antigenemia assay 12.1.4. Polymerase Chain Reaction Amplification 12.1.5. Immunohistochemistry 12.1.6. Nucleic acid sequence-based amplification (NASBA) 12.1.7. Hybrid capture assay 12.2. Application Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.2.1. Retinitis 12.2.2. Pneumonia 12.2.3. Gastrointestinal Ulcers 12.2.4. Encephalitis 12.2.5. Others (Mouth Ulcers, Pharyngitis, etc.) 12.3. End User Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.3.1. Hospitals 12.3.2. Diagnostic Centers 12.3.3. Others 12.4. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 12.4.1. Brazil 12.4.2. Mexico 12.4.3. Argentina 12.4.4. Venezuela 12.4.5. Rest of Latin America 12.5. Latin America Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024 12.6. Latin America Cytomegalovirus Diagnostics Market Dynamics – Trends 13. Middle East and Africa Cytomegalovirus Diagnostics Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 13.1. Test Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 13.1.1. Serology 13.1.2. Cell culture 13.1.3. Antigenemia assay 13.1.4. Polymerase Chain Reaction Amplification 13.1.5. Immunohistochemistry 13.1.6. Nucleic acid sequence-based amplification (NASBA) 13.1.7. Hybrid capture assay 13.2. Application Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 13.2.1. Retinitis 13.2.2. Pneumonia 13.2.3. Gastrointestinal Ulcers 13.2.4. Encephalitis 13.2.5. Others (Mouth Ulcers, Pharyngitis, etc.) 13.3. End User Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 13.3.1. Hospitals 13.3.2. Diagnostic Centers 13.3.3. Others 13.4. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 13.4.1. Gulf Cooperation Council (GCC) Countries 13.4.2. Israel 13.4.3. South Africa 13.4.4. Rest of MEA 13.5. MEA Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024 13.6. MEA Cytomegalovirus Diagnostics Market Dynamics – Trends 14. Competition Landscape 14.1. Strategic Dashboard of Top Market Players 14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) 14.2.1. Cell Medical Ltd. (U.K.) 14.2.2. Merck & Co. Inc. (U.S.) 14.2.3. Chimerix, Inc. (U.S.) 14.2.4. Abbott Laboratories (U.S.) 14.2.5. Affymetrix, Inc. (U.S.) 14.2.6. Becton, Dickinson and Company (U.S.) 14.2.7. Bio-Rad Laboratories, Inc. (U.S.) 14.2.8. F. Hoffmann-La Roche Ltd.( Switzerland) 14.2.9. Johnson and Johnson Services Inc.,(U.S.) 15. Research Methodology 16. Key Assumptions and Acronyms
  • Cell Medical Ltd. (U.K.)
  • Merck & Co. Inc. (U.S.)
  • Chimerix, Inc. (U.S.)
  • Abbott Laboratories (U.S.)
  • Affymetrix, Inc. (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd.( Switzerland)
  • Johnson and Johnson Services Inc.,(U.S.)